VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-04-04

AUTHORS

Hideaki Yamamoto, Tappei Takada, Yoshihide Yamanashi, Masatsune Ogura, Yusuke Masuo, Mariko Harada-Shiba, Hiroshi Suzuki

ABSTRACT

Only free drugs have been believed to be carried into tissues through active or passive transport. However, considering that lipoproteins function as carriers of serum lipids such as cholesterol and triglycerides, we hypothesized that lipoproteins can associate with certain drugs and mediate their transport into tissues in lipid-associated form. Here, in vitro and in vivo studies with low density lipoprotein receptor (LDLR)-overexpressing or -knockdown cells and wild-type or LDLR-mutant mice were used to show the association of various drugs with lipoproteins and the uptake of lipoprotein-associated drugs through a lipoprotein receptor-mediated process. In clinical studies, investigation of the effect of lipoprotein apheresis on serum drug concentrations in patients with familial hypercholesterolemia demonstrated that lipoprotein-mediated drug transport occurs in humans as well as in mice. These findings represent a new concept regarding the transport and metabolism of drugs in the body and suggest that the role of lipoprotein-mediated drug transport should be considered when developing effective and safe pharmacotherapies. More... »

PAGES

633

References to SciGraph publications

  • 2011-08-05. BDDCS Applied to Over 900 Drugs in THE AAPS JOURNAL
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41598-017-00685-9

    DOI

    http://dx.doi.org/10.1038/s41598-017-00685-9

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1084130798

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/28377633


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Pharmacology and Pharmaceutical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Amlodipine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biological Transport", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cholesterol", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Carriers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hyperlipoproteinemia Type II", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lipoproteins, LDL", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lipoproteins, VLDL", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pharmaceutical Preparations", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Binding", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, LDL", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Ticlopidine", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.412708.8", 
              "name": [
                "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yamamoto", 
            "givenName": "Hideaki", 
            "id": "sg:person.01321723474.97", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321723474.97"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.412708.8", 
              "name": [
                "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Takada", 
            "givenName": "Tappei", 
            "id": "sg:person.01251420706.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251420706.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.412708.8", 
              "name": [
                "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yamanashi", 
            "givenName": "Yoshihide", 
            "id": "sg:person.01354032631.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354032631.31"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 565-8565, Osaka, Japan", 
              "id": "http://www.grid.ac/institutes/grid.410796.d", 
              "name": [
                "Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 565-8565, Osaka, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ogura", 
            "givenName": "Masatsune", 
            "id": "sg:person.01126565760.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126565760.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.412708.8", 
              "name": [
                "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Masuo", 
            "givenName": "Yusuke", 
            "id": "sg:person.0613004507.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613004507.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 565-8565, Osaka, Japan", 
              "id": "http://www.grid.ac/institutes/grid.410796.d", 
              "name": [
                "Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 565-8565, Osaka, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Harada-Shiba", 
            "givenName": "Mariko", 
            "id": "sg:person.01211161001.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211161001.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan", 
              "id": "http://www.grid.ac/institutes/grid.412708.8", 
              "name": [
                "Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Suzuki", 
            "givenName": "Hiroshi", 
            "id": "sg:person.012555337103.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012555337103.96"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1208/s12248-011-9290-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002856067", 
              "https://doi.org/10.1208/s12248-011-9290-9"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2017-04-04", 
        "datePublishedReg": "2017-04-04", 
        "description": "Only free drugs have been believed to be carried into tissues through active or passive transport. However,\u00a0considering that lipoproteins function as carriers of serum lipids such as cholesterol and triglycerides, we\u00a0hypothesized that lipoproteins can associate with certain drugs and mediate their transport into tissues in lipid-associated form. Here, in vitro and in vivo studies with low density lipoprotein receptor (LDLR)-overexpressing or -knockdown cells and wild-type or LDLR-mutant mice were used to show the association of various drugs with lipoproteins and the uptake of lipoprotein-associated drugs through a lipoprotein receptor-mediated process. In clinical studies, investigation of the effect of lipoprotein apheresis on serum drug concentrations in patients with familial hypercholesterolemia demonstrated that lipoprotein-mediated drug transport occurs in humans as well as in mice. These findings represent a new concept regarding the transport and metabolism of drugs in the body and suggest that the role of lipoprotein-mediated drug transport should be considered when developing effective and safe pharmacotherapies.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41598-017-00685-9", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.5922176", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.6035397", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.9339353", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5915498", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5875784", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5872235", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1045337", 
            "issn": [
              "2045-2322"
            ], 
            "name": "Scientific Reports", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "7"
          }
        ], 
        "keywords": [
          "metabolism of drugs", 
          "serum drug concentrations", 
          "low-density lipoprotein receptor", 
          "uptake of lipoproteins", 
          "VLDL/LDL", 
          "receptor-mediated process", 
          "density lipoprotein receptor", 
          "drug transport", 
          "serum lipids", 
          "lipoprotein apheresis", 
          "safe pharmacotherapy", 
          "lipoprotein function", 
          "clinical studies", 
          "familial hypercholesterolemia", 
          "lipoprotein receptor", 
          "certain drugs", 
          "drug concentrations", 
          "vivo studies", 
          "drugs", 
          "lipoprotein", 
          "free drug", 
          "mice", 
          "lipid-associated form", 
          "knockdown cells", 
          "tissue", 
          "metabolism", 
          "pharmacotherapy", 
          "patients", 
          "hypercholesterolemia", 
          "LDL", 
          "apheresis", 
          "triglycerides", 
          "cholesterol", 
          "receptors", 
          "study", 
          "association", 
          "drug carriers", 
          "cells", 
          "lipids", 
          "humans", 
          "passive transport", 
          "body", 
          "findings", 
          "uptake", 
          "carriers", 
          "role", 
          "effect", 
          "concentration", 
          "function", 
          "investigation", 
          "transport", 
          "form", 
          "new concept", 
          "process", 
          "concept"
        ], 
        "name": "VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body", 
        "pagination": "633", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1084130798"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41598-017-00685-9"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "28377633"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41598-017-00685-9", 
          "https://app.dimensions.ai/details/publication/pub.1084130798"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T21:03", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_751.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41598-017-00685-9"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-00685-9'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-00685-9'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-00685-9'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-017-00685-9'


     

    This table displays all metadata directly associated to this object as RDF triples.

    232 TRIPLES      21 PREDICATES      95 URIs      86 LITERALS      21 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41598-017-00685-9 schema:about N135f04097ae743a1844aabd9207af980
    2 N4765f29989974d7f8f0561df7c4c10fd
    3 N6833cf17361c40ed81874271a83c04fb
    4 N6e9791b2a4b94510885b0dc606779ddd
    5 N7a1023e77f7f4eb2a07b589851caf2ba
    6 N84fda9b48af648c09798eb01cd23b770
    7 N8a3c66c0c6274195928a02c8334de0e9
    8 N96a836f95bfa4258a17254e1fefbb300
    9 Na19d9339b35440dcbf165a5487b1df7d
    10 Na3a7b625e87541fabccaffcb5f917da2
    11 Nb8a12f9b857c4c93b25ae5e17ab50dde
    12 Nc71917892c374cacbba4227e19a260e3
    13 Nd166cb6bce4647e2a7ce9fa19f29f96d
    14 Nfbe0ddbdf2144c8ba25e79bd870fa921
    15 anzsrc-for:11
    16 anzsrc-for:1115
    17 schema:author N66cf71b9ef6c4bb9a9208ded86c42ef3
    18 schema:citation sg:pub.10.1208/s12248-011-9290-9
    19 schema:datePublished 2017-04-04
    20 schema:datePublishedReg 2017-04-04
    21 schema:description Only free drugs have been believed to be carried into tissues through active or passive transport. However, considering that lipoproteins function as carriers of serum lipids such as cholesterol and triglycerides, we hypothesized that lipoproteins can associate with certain drugs and mediate their transport into tissues in lipid-associated form. Here, in vitro and in vivo studies with low density lipoprotein receptor (LDLR)-overexpressing or -knockdown cells and wild-type or LDLR-mutant mice were used to show the association of various drugs with lipoproteins and the uptake of lipoprotein-associated drugs through a lipoprotein receptor-mediated process. In clinical studies, investigation of the effect of lipoprotein apheresis on serum drug concentrations in patients with familial hypercholesterolemia demonstrated that lipoprotein-mediated drug transport occurs in humans as well as in mice. These findings represent a new concept regarding the transport and metabolism of drugs in the body and suggest that the role of lipoprotein-mediated drug transport should be considered when developing effective and safe pharmacotherapies.
    22 schema:genre article
    23 schema:isAccessibleForFree true
    24 schema:isPartOf N425251b89de84e18bb9b0df144a81ad5
    25 N8274ae8df0094214a05e445be991562a
    26 sg:journal.1045337
    27 schema:keywords LDL
    28 VLDL/LDL
    29 apheresis
    30 association
    31 body
    32 carriers
    33 cells
    34 certain drugs
    35 cholesterol
    36 clinical studies
    37 concentration
    38 concept
    39 density lipoprotein receptor
    40 drug carriers
    41 drug concentrations
    42 drug transport
    43 drugs
    44 effect
    45 familial hypercholesterolemia
    46 findings
    47 form
    48 free drug
    49 function
    50 humans
    51 hypercholesterolemia
    52 investigation
    53 knockdown cells
    54 lipid-associated form
    55 lipids
    56 lipoprotein
    57 lipoprotein apheresis
    58 lipoprotein function
    59 lipoprotein receptor
    60 low-density lipoprotein receptor
    61 metabolism
    62 metabolism of drugs
    63 mice
    64 new concept
    65 passive transport
    66 patients
    67 pharmacotherapy
    68 process
    69 receptor-mediated process
    70 receptors
    71 role
    72 safe pharmacotherapy
    73 serum drug concentrations
    74 serum lipids
    75 study
    76 tissue
    77 transport
    78 triglycerides
    79 uptake
    80 uptake of lipoproteins
    81 vivo studies
    82 schema:name VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body
    83 schema:pagination 633
    84 schema:productId N144807f5d66243d7971cb7315a66ac29
    85 Nb349ce7970044e7a8968cbc05ea2b246
    86 Nce50b0b363164f31b5064635d8c8a87a
    87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084130798
    88 https://doi.org/10.1038/s41598-017-00685-9
    89 schema:sdDatePublished 2022-11-24T21:03
    90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    91 schema:sdPublisher N859c21db788845958d163ac9f509dc81
    92 schema:url https://doi.org/10.1038/s41598-017-00685-9
    93 sgo:license sg:explorer/license/
    94 sgo:sdDataset articles
    95 rdf:type schema:ScholarlyArticle
    96 N02dbd8406ac6402eb93483d7d226b9ab rdf:first sg:person.01354032631.31
    97 rdf:rest N9727dc4121554170b5e682ceb2fbcb76
    98 N0b731e6a3a5048bb9349f81100ea6cee rdf:first sg:person.01251420706.49
    99 rdf:rest N02dbd8406ac6402eb93483d7d226b9ab
    100 N135f04097ae743a1844aabd9207af980 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    101 schema:name Ticlopidine
    102 rdf:type schema:DefinedTerm
    103 N144807f5d66243d7971cb7315a66ac29 schema:name dimensions_id
    104 schema:value pub.1084130798
    105 rdf:type schema:PropertyValue
    106 N26a6a8ee35b94516940de25ed85642eb rdf:first sg:person.01211161001.30
    107 rdf:rest Nedf7edce5b79495ba3a77e88596e67a4
    108 N425251b89de84e18bb9b0df144a81ad5 schema:volumeNumber 7
    109 rdf:type schema:PublicationVolume
    110 N4765f29989974d7f8f0561df7c4c10fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name Cholesterol
    112 rdf:type schema:DefinedTerm
    113 N66cf71b9ef6c4bb9a9208ded86c42ef3 rdf:first sg:person.01321723474.97
    114 rdf:rest N0b731e6a3a5048bb9349f81100ea6cee
    115 N6833cf17361c40ed81874271a83c04fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Hyperlipoproteinemia Type II
    117 rdf:type schema:DefinedTerm
    118 N6e9791b2a4b94510885b0dc606779ddd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Lipoproteins, VLDL
    120 rdf:type schema:DefinedTerm
    121 N7a1023e77f7f4eb2a07b589851caf2ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Drug Carriers
    123 rdf:type schema:DefinedTerm
    124 N8274ae8df0094214a05e445be991562a schema:issueNumber 1
    125 rdf:type schema:PublicationIssue
    126 N84fda9b48af648c09798eb01cd23b770 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Lipoproteins, LDL
    128 rdf:type schema:DefinedTerm
    129 N859c21db788845958d163ac9f509dc81 schema:name Springer Nature - SN SciGraph project
    130 rdf:type schema:Organization
    131 N8a3c66c0c6274195928a02c8334de0e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Animals
    133 rdf:type schema:DefinedTerm
    134 N96a836f95bfa4258a17254e1fefbb300 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Receptors, LDL
    136 rdf:type schema:DefinedTerm
    137 N9727dc4121554170b5e682ceb2fbcb76 rdf:first sg:person.01126565760.33
    138 rdf:rest Nd86f2c9b88ba42439f73b58164663de1
    139 Na19d9339b35440dcbf165a5487b1df7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    140 schema:name Biological Transport
    141 rdf:type schema:DefinedTerm
    142 Na3a7b625e87541fabccaffcb5f917da2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Male
    144 rdf:type schema:DefinedTerm
    145 Nb349ce7970044e7a8968cbc05ea2b246 schema:name doi
    146 schema:value 10.1038/s41598-017-00685-9
    147 rdf:type schema:PropertyValue
    148 Nb8a12f9b857c4c93b25ae5e17ab50dde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Amlodipine
    150 rdf:type schema:DefinedTerm
    151 Nc71917892c374cacbba4227e19a260e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Pharmaceutical Preparations
    153 rdf:type schema:DefinedTerm
    154 Nce50b0b363164f31b5064635d8c8a87a schema:name pubmed_id
    155 schema:value 28377633
    156 rdf:type schema:PropertyValue
    157 Nd166cb6bce4647e2a7ce9fa19f29f96d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Protein Binding
    159 rdf:type schema:DefinedTerm
    160 Nd86f2c9b88ba42439f73b58164663de1 rdf:first sg:person.0613004507.35
    161 rdf:rest N26a6a8ee35b94516940de25ed85642eb
    162 Nedf7edce5b79495ba3a77e88596e67a4 rdf:first sg:person.012555337103.96
    163 rdf:rest rdf:nil
    164 Nfbe0ddbdf2144c8ba25e79bd870fa921 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Mice
    166 rdf:type schema:DefinedTerm
    167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    168 schema:name Medical and Health Sciences
    169 rdf:type schema:DefinedTerm
    170 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
    171 schema:name Pharmacology and Pharmaceutical Sciences
    172 rdf:type schema:DefinedTerm
    173 sg:grant.5872235 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-017-00685-9
    174 rdf:type schema:MonetaryGrant
    175 sg:grant.5875784 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-017-00685-9
    176 rdf:type schema:MonetaryGrant
    177 sg:grant.5915498 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-017-00685-9
    178 rdf:type schema:MonetaryGrant
    179 sg:grant.5922176 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-017-00685-9
    180 rdf:type schema:MonetaryGrant
    181 sg:grant.6035397 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-017-00685-9
    182 rdf:type schema:MonetaryGrant
    183 sg:grant.9339353 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-017-00685-9
    184 rdf:type schema:MonetaryGrant
    185 sg:journal.1045337 schema:issn 2045-2322
    186 schema:name Scientific Reports
    187 schema:publisher Springer Nature
    188 rdf:type schema:Periodical
    189 sg:person.01126565760.33 schema:affiliation grid-institutes:grid.410796.d
    190 schema:familyName Ogura
    191 schema:givenName Masatsune
    192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126565760.33
    193 rdf:type schema:Person
    194 sg:person.01211161001.30 schema:affiliation grid-institutes:grid.410796.d
    195 schema:familyName Harada-Shiba
    196 schema:givenName Mariko
    197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211161001.30
    198 rdf:type schema:Person
    199 sg:person.01251420706.49 schema:affiliation grid-institutes:grid.412708.8
    200 schema:familyName Takada
    201 schema:givenName Tappei
    202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251420706.49
    203 rdf:type schema:Person
    204 sg:person.012555337103.96 schema:affiliation grid-institutes:grid.412708.8
    205 schema:familyName Suzuki
    206 schema:givenName Hiroshi
    207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012555337103.96
    208 rdf:type schema:Person
    209 sg:person.01321723474.97 schema:affiliation grid-institutes:grid.412708.8
    210 schema:familyName Yamamoto
    211 schema:givenName Hideaki
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321723474.97
    213 rdf:type schema:Person
    214 sg:person.01354032631.31 schema:affiliation grid-institutes:grid.412708.8
    215 schema:familyName Yamanashi
    216 schema:givenName Yoshihide
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354032631.31
    218 rdf:type schema:Person
    219 sg:person.0613004507.35 schema:affiliation grid-institutes:grid.412708.8
    220 schema:familyName Masuo
    221 schema:givenName Yusuke
    222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613004507.35
    223 rdf:type schema:Person
    224 sg:pub.10.1208/s12248-011-9290-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002856067
    225 https://doi.org/10.1208/s12248-011-9290-9
    226 rdf:type schema:CreativeWork
    227 grid-institutes:grid.410796.d schema:alternateName Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 565-8565, Osaka, Japan
    228 schema:name Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 565-8565, Osaka, Japan
    229 rdf:type schema:Organization
    230 grid-institutes:grid.412708.8 schema:alternateName Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan
    231 schema:name Department of Pharmacy, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, 113-8655, Tokyo, Japan
    232 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...